After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...

The pivotal trial that established sildenafil as a treatment for WHO Group 1 PH was the SUPER ... Phosphodiesterase type 5; PH: Pulmonary hypertension.

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

Many roadblocks exist to detecting and assessing pulmonary hypertension (PH) in patients with interstitial lung disease (ILD), but creative thinking and artificial intelligence (AI) may soon help ...

Steve Van Wormer has published nearly 500 podcasts about pulmonary hypertension (PH) — more than perhaps anyone working in rare diseases.

According to the study’s webpage on ClinicalTrials.gov, researchers will assess patients aged 3 months to 18 years with World Symposium on Pulmonary Hypertension Groups 1 and 3 PAH in this ...